Allergan Plc

Columbus Hill Capital Management seeks to achieve attractive returns over a multi-year period through all phases of the market cycle by applying a multi-disciplinary approach to investing and maintaining a focus on capital preservation. They strive to achieve their investment objectives by utilizing the following strategies: (1) high-yield bonds, stressed and defaulted debt and equity securities, post-reorganization equity securities, bank loans (including first lien, second lien and debtor-in-possession bank loans), credit default swaps and other debt and equity securities, including sovereign debt securities; (2) event-driven investments, such as investments made as a result of third party litigations, corporate reorganizations, bankruptcies, and mergers and acquisitions; and (3) investments in private companies and special situations investments. Columbus Hill may invest worldwide in U.S. and non-U.S. securities and other instruments, including: (1) equities (listed, unlisted, traded or privately offered, domestic, foreign, American depository receipts and preferred); (2) secured and unsecured debt (both corporate and sovereign, bank loans, and other legal and/or contractual claims); (3) convertible bonds and preferred stock; and (4) derivative instruments, including listed and over-the-counter options, futures, forward contracts, swaps, caps, floors, and other equity and fixed income related instruments, and contracts for differences.

Columbus Hill Capital Management seeks to achieve attractive returns over a multi-year period through all phases of the market cycle by applying a multi-disciplinary approach to investing and maintaining a focus on capital preservation. They strive to achieve their investment objectives by utilizing the following strategies: (1) high-yield bonds, stressed and defaulted debt and equity securities, post-reorganization equity securities, bank loans (including first lien, second lien and debtor-in-possession bank loans), credit default swaps and other debt and equity securities, including sovereign debt securities; (2) event-driven investments, such as investments made as a result of third party litigations, corporate reorganizations, bankruptcies, and mergers and acquisitions; and (3) investments in private companies and special situations investments. Columbus Hill may invest worldwide in U.S. and non-U.S. securities and other instruments, including: (1) equities (listed, unlisted, traded or privately offered, domestic, foreign, American depository receipts and preferred); (2) secured and unsecured debt (both corporate and sovereign, bank loans, and other legal and/or contractual claims); (3) convertible bonds and preferred stock; and (4) derivative instruments, including listed and over-the-counter options, futures, forward contracts, swaps, caps, floors, and other equity and fixed income related instruments, and contracts for differences.

Chief Executive Officer at Innocrin Pharmaceuticals, Inc.

Co-Founder at Longitude Capital Management Co. LLC

Investor at Neuronetics, Inc.